Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRC | Q99895 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL8595692 | 0.97 | CTRC (0.35) | CTRCGABRA1GABRB2ALDH1A1TSHR | |
| Ammonia Solution, Strong SCHEMBL135221 | 0.97 | CTRC (0.35) | CTRCGABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL6915878 | 0.95 | CTRC (0.39) | CTRCGABRA1GABRB2 | |
| SCHEMBL7705299 | 0.95 | CTRC (0.39) | CTRCGABRA1GABRB2 | |
| SCHEMBL6917622 | 0.95 | CTRC (0.34) | CTRCGABRA1GABRB2 | |
| SCHEMBL29619533 | 0.86 | GABRA1 (0.41) | CTRCGABRA1GABRB2ALDH1A1 | |
| SCHEMBL166573 | 0.86 | GABRA1 (0.41) | CTRCGABRA1GABRB2ALDH1A1 | |
| SCHEMBL27829682 | 0.85 | GABRA1 (0.46) | GABRA1GABRB2ALDH1A1TSHR | |
| Ammonia Solution, Strong SCHEMBL17239637 | 0.83 | GABRA1 (0.44) | GABRA1GABRB2ALDH1A1TSHR | |
| Ammonia Solution, Strong SCHEMBL27539208 | 0.83 | GABRA1 (0.39) | CTRCGABRA1GABRB2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114259996-A | Spherical rhenium directional adsorbent and application method thereof | 洛阳双罗铼材料科技有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-114214528-A | Preparation method of high-purity ammonium rhenate | 洛阳双罗铼材料科技有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-109320671-B | Preparation of epoxy acrylic acid extraction resin and application of epoxy acrylic acid extraction resin in germanium extraction | 辽宁大学 | 2021-01-08 | — | — | CN | claimed |
| JP-9157340-A | — | — | None | — | — | JP | disclosed |
| US-12624355-B2 | Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof | Suzhou Ribo Life Science Co., Ltd. (CN) | 2026-05-12 | — | — | US | disclosed |
| US-12428642-B2 | Nucleic acid, composition and conjugate comprising the same, preparation method and use thereof | Suzhou Ribo Life Science Co., Ltd. (CN) | 2025-09-30 | — | — | US | disclosed |
| US-12274752-B2 | Nucleic acid, composition and conjugate containing same, preparation method, and use thereof | Suzhou Ribo Life Science Co., Ltd. (CN) | 2025-04-15 | — | — | US | disclosed |
| EP-4527459-A2 | NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF | Suzhou Ribo Life Science Co., Ltd. (CN) | 2025-03-26 | — | — | EP | disclosed |
| EP-3732185-B1 | CONJUGATES AND PREPARATION AND USE THEREOF | SUZHOU RIBO LIFE SCIENCE CO LTD (CN) | 2025-02-26 | — | — | EP | disclosed |
| EP-3719128-B1 | DOUBLE-STRANDED OLIGONUCLEOTIDE, COMPOSITION AND CONJUGATE COMPRISING DOUBLE-STRANDED OLIGONUCLEOTIDE, PREPARATION METHOD THEREFOR AND USE THEREOF | SUZHOU RIBO LIFE SCIENCE CO LTD (CN) | 2025-01-15 | — | — | EP | disclosed |
| EP-3719125-B1 | NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, AND PREPARATION METHOD AND USE | SUZHOU RIBO LIFE SCIENCE CO LTD (CN) | 2025-01-08 | — | — | EP | disclosed |
| EP-2167516-B1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | OPKO IP HOLDINGS II INC (KY) | 2015-07-22 | — | — | EP | disclosed |
| US-8039676-B2 | Process for producing phosphine oxide vitamin D precursors | CYTOCHROMA INC. (CA) | 2011-10-18 | — | — | US | disclosed |
| US-8030382-B2 | Polylactic acid composition | TEIJIN LIMITED (JP) | 2011-10-04 | — | — | US | disclosed |
| US-20100093888-A1 | POLYLACTIC ACID COMPOSITION | TEIJIN LIMITED (JP) | 2010-04-15 | — | — | US | disclosed |
| EP-2167516-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | Cytochroma Inc. (CA) | 2010-03-31 | — | — | EP | disclosed |
| EP-2116576-A1 | POLYLACTIC ACID COMPOSITION | Teijin Limited (JP) | 2009-11-11 | — | — | EP | disclosed |
| US-20080300427-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | EIRGEN PHARMA LTD. (IE) | 2008-12-04 | — | — | US | disclosed |
| WO-2008146130-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | CYTOCHROMA INC. (CA) | 2008-12-04 | — | — | WO | disclosed |
| JP-H09157340-A | NOVEL HEAT-RESISTANT RESIN | KYOEISHA CHEM CO LTD | 1997-06-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624355-B2 | Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof | RNGTT, RNMT, NSUN2 | CTRC 4233/4885GABRA1 2439/4885GABRB2 2130/4885 |
| US-12274752-B2 | Nucleic acid, composition and conjugate containing same, preparation method, and use thereof | APOB, C1QBP, APOL1 | CTRC 302/4885GABRA1 4207/4885GABRB2 4232/4885 |
| US-12428642-B2 | Nucleic acid, composition and conjugate comprising the same, preparation method and use thereof | TEK, TIE1, IGF2BP3 | CTRC 2949/4885GABRA1 4322/4885GABRB2 4459/4885 |
| US-20080300427-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | CYP24A1, VDR, FRG1 | CTRC 2889/4885GABRA1 4391/4885GABRB2 4580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.